A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming
Elisabetta Mori, Elisa De Santis, Marta Scalera, Julia Meissel, Elena Ellmeier, Alessandra Flori, Luca Menichetti, Gudula Schmidt, Antonino Cattaneo, Stefano Angiari, Mario Costa, Eleonora Vannini · 2026
Read A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming by Elisabetta Mori, Elisa De Santis, Marta Scalera, Julia Meissel, Elena Ellmeier, Alessandra Flori, Luca Menichetti, Gudula Schmidt, Antonino Cattaneo, Stefano Angiari, Mario Costa, Eleonora Vannini (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13435415.txt.
Description
Elisabetta Mori's team built a brain-penetrant protein in 2026 to attack glioblastoma, the most aggressive primary brain tumor, on two fronts at once. The fusion joins chlorotoxin, which ferries cargo across the blood-brain barrier to tumor cells, with CNF1, a bacterial protein that stirs anti-tumor immunity. Tests ran in immune-competent mouse models of brain tumors, tracking survival, scans, movement, and immune cells.
Treated mice lived longer, carried smaller tumors, kept movement, and many cleared tumors fully and resisted a second tumor challenge. The protein reprogrammed tumor-linked myeloid cells toward inflammation and drew in killer T cells, and it also boosted checkpoint therapy in some settings. Brain tumor teams get a dual-action lead, still at the animal stage.
Catalog record
| CREATOR | Elisabetta Mori, Elisa De Santis, Marta Scalera, Julia Meissel, Elena Ellmeier, Alessandra Flori, Luca Menichetti, Gudula Schmidt, Antonino Cattaneo, Stefano Angiari, Mario Costa, Eleonora Vannini |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |